You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Drug Price Trends for HM ANTACID EX-STR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM ANTACID EX-STR

Average Pharmacy Cost for HM ANTACID EX-STR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM ANTACID EX-STR 750 MG CHEW 62011-0397-01 0.03250 EACH 2025-02-19
HM ANTACID EX-STR 750 MG CHEW 62011-0397-01 0.03208 EACH 2025-01-22
HM ANTACID EX-STR 750 MG CHEW 62011-0397-01 0.03230 EACH 2024-12-18
HM ANTACID EX-STR 750 MG CHEW 62011-0397-01 0.03264 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Antacids: A Comprehensive Overview

Introduction to the Antacids Market

The antacids market, which includes products like HM Antacid, is a significant segment within the pharmaceutical industry. These medications are designed to alleviate symptoms of heartburn, indigestion, and gastroesophageal reflux disease (GERD) by neutralizing stomach acid.

Global Antacids Market Size and Growth

The global antacids market is substantial and growing steadily. As of 2024, the market size was valued at approximately USD 7.47 billion and is projected to reach USD 10.33 billion by 2034, growing at a CAGR of 3.30% during this period[1].

Another report indicates that the market was valued at USD 7.2 billion in 2022 and is expected to grow to USD 10.9 billion by 2032, with a CAGR of 4.8% from 2023 to 2032[4].

Key Drivers of Market Growth

Several factors are driving the growth of the antacids market:

Rising Prevalence of GERD and Heartburn

The increasing incidence of GERD and heartburn is a major driver. Approximately 784 million individuals worldwide are affected by these conditions, propelling the demand for antacids[1].

Ease of Access and Availability

The ease of access to over-the-counter (OTC) antacids and their improved availability contribute significantly to market growth. Online pharmacies, in particular, are expected to see rapid growth due to the rising popularity of online shopping and improvements in telecom services[3].

Consumer Awareness and Disposable Income

In regions like the Asia Pacific, rising disposable income and increased consumer awareness about the availability of antacids are boosting market growth[1].

Market Segmentation

The antacids market can be segmented in several ways:

By Drug Class

  • Proton Pump Inhibitors (PPIs)
  • H2-Receptor Antagonists
  • Acid Neutralizers[4]

By Formulation Type

  • Tablets
  • Liquids
  • Powders
  • Others[4]

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy[4]

Regional Analysis

The Asia Pacific region is expected to be the fastest-growing market due to high unmet clinical needs, efficient treatment options, and rising consumer awareness. Other significant regions include North America, Europe, Latin America, and the Middle East & Africa[1][4].

Key Players in the Market

Major players in the antacids market include:

  • Takeda Pharmaceutical Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Reckitt Benckiser Group plc
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Bayer AG
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Procter & Gamble[1][4].

Pricing and Cost Considerations

The pricing of antacids can vary based on the formulation, distribution channel, and geographical location. Here are some general insights:

Cost Structure

Antacids are generally affordable and often available OTC. For instance, generic antacids can be found at a low cost, with copays ranging from $0 to $5 for a 30-day supply under certain Medicare plans[2].

Online Pharmacy Impact

Sales through online pharmacies are expected to grow faster due to convenience and accessibility. This could influence pricing strategies, with online retailers potentially offering competitive prices to attract more customers[3].

Side Effects and Safety Considerations

While antacids like HM Antacid are generally safe, they can have side effects such as nausea, constipation, diarrhea, or headache. The magnesium in these products can cause diarrhea, while aluminum can cause constipation. Long-term use can also lead to low phosphate levels, which require medical attention[5].

Marketing Strategies

To strategically expand in the global antacids market, companies must conduct meticulous market research to understand prevailing trends and consumer preferences. Here are some key strategies:

Customized Products

Developing innovative antacid formulations that address specific consumer needs can differentiate a company from its competitors and foster brand loyalty[1].

Comprehensive Marketing

Investing in encompassing marketing strategies, including creating captivating stories, using various media, and launching focused advertising, is crucial for market expansion[1].

Price Projections

Given the projected market growth, here are some price projection insights:

Market Size Growth

The market is expected to grow from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, indicating a steady increase in demand and potentially stable or slightly increasing prices due to economies of scale[1].

Competitive Pricing

With multiple players in the market, pricing is likely to remain competitive. Companies may focus on differentiating their products through innovative formulations and strong marketing rather than significantly increasing prices[4].

Key Takeaways

  • The global antacids market is growing steadily, driven by the rising prevalence of GERD and heartburn.
  • The market is expected to reach USD 10.33 billion by 2034, growing at a CAGR of 3.30% from 2024 to 2034.
  • Online pharmacies are expected to play a significant role in market growth.
  • Key players are investing in innovative formulations and comprehensive marketing strategies.
  • Pricing is likely to remain competitive, with a focus on product differentiation.

FAQs

Q: What is the current size of the global antacids market?

The global antacids market was valued at approximately USD 7.47 billion in 2024[1].

Q: What is the projected growth rate of the antacids market?

The market is expected to grow at a CAGR of 3.30% from 2024 to 2034[1].

Q: Which region is expected to have the fastest-growing antacids market?

The Asia Pacific region is expected to be the fastest-growing market due to several factors, including high unmet clinical needs and rising consumer awareness[1].

Q: What are the common side effects of antacids like HM Antacid?

Common side effects include nausea, constipation, diarrhea, or headache. Long-term use can also lead to low phosphate levels[5].

Q: How are online pharmacies impacting the antacids market?

Online pharmacies are expected to see rapid growth due to the rising popularity of online shopping and improvements in telecom services, with sales projected to increase at a CAGR of 5%[3].

Sources

  1. Towards Healthcare: Antacids Market Size, Trends & 3.30% CAGR Growth by 2034
  2. UCare: 2025 UCare Medicare Group Formulary
  3. Fact.MR: Antacids Market Size, Share, Demand & Growth Analysis, 2033
  4. Acumen Research and Consulting: Antacids Market Size, Share, Trends | Forecast 2032
  5. WebMD: HM Antacid Suspension - Uses, Side Effects, and More

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.